How did M&A perform in pharmaceutical in Q4 2023?
In the global pharmaceutical industry, there were 426 M&A deals announced in Q4 2023, worth a total value of $84.2bn,…
In the global pharmaceutical industry, there were 426 M&A deals announced in Q4 2023, worth a total value of $84.2bn,…
In the Asia-Pacific pharmaceutical industry, there were 10 private equity deals announced in Q4 2023, worth a total value of…
In the global pharmaceutical industry, there were 66 private equity deals announced in Q4 2023, worth a total value of…
In the Chinese pharmaceutical industry, there were 2 private equity deals announced in Q4 2023, worth a total value of…
In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total…
In the Indian pharmaceutical industry, there were 3 private equity deals announced in Q4 2023, worth a total value of…
In the Australian pharmaceutical industry, there were 6 M&A deals announced in Q4 2023, worth a total value of $276.3m,…
In the British pharmaceutical industry, there were 6 private equity deals announced in Q4 2023, worth a total value of…
In the South and Central America pharmaceutical industry, there were 5 M&A deals announced in Q4 2023, worth a total…
In the Chinese pharmaceutical industry, there were 29 M&A deals announced in Q4 2023, worth a total value of $3.5bn,…